Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Pharmacodynamics of Cardionat in Healthy Athletes
NCT02758912Phase 4Completed
- Sponsor
- Burnasyan Federal Medical Biophysical Center
- Start
- Nov 2016
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of meldonium in angina pectoris, stroke, heart failure (HF), sponsored by Burnasyan Federal Medical Biophysical Center. Started Nov 2016; status: completed.
02
Drugs
meldonium
03
Conditions
angina pectorisstrokeheart failure (HF)
Beyond the preview
Go deeper on NCT02758912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02758912.